Orally rapidly disintegrating tablet, and process for producing same

An oral fast disintegrating tablet, oral technology, applied in the direction of pharmaceutical formulations, medical preparations with inactive ingredients, and medical preparations containing active ingredients, etc., can solve the problems of bad tongue, deterioration of preparation properties, and high hygroscopicity

Active Publication Date: 2011-10-19
MITSUBISHI TANABE PHARMA CORP
View PDF9 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this invention has the disadvantage that micronized mannitol used as a formulation ingredient causes tableting defects, such as sticking to the die and punch, and reduces the fluidity of the mixture for tableting
These tablets have disadvantages such as unpleasant sensation on the tongue when taken due to the relatively high amount of water-insoluble ingredients contained in the tablet
However, these inventions have the disadvantage that the hardness of the tablet tends to decrease during storage due to the high hygroscopicity of the water-insoluble hydrophilic ingredients
[0009] Since the above-mentioned single-dose packaging causes the preparation to be exposed to the air for a given period of time from taking the preparation out of the blister pack to packaging it into a single dose, changes in the properties of the preparation due to hygroscopicity, etc., are a concern
At the same time, the single-dose packaging material does not drain as well compared to blister packs, so for hygroscopic preparations, severe deterioration of the preparation properties before administration (especially tablet hardness) is also a concern. concerns

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Orally rapidly disintegrating tablet, and process for producing same
  • Orally rapidly disintegrating tablet, and process for producing same
  • Orally rapidly disintegrating tablet, and process for producing same

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0083]Excipients (97 parts by weight (or 90 parts by weight)) and water-insoluble A mixture (300 mg) of polymer (hydroxypropylmethylcellulose acetate succinate, HPMC-AS, grade: HF) (3 parts by weight (or 10 parts by weight)) was compression-molded to obtain tablets. The water wettability (wetting time) and hardness of each tablet were measured according to the following evaluation procedure, and based on the measurement results (see Table 1 below), the excipients were divided into the following 2 groups.

[0084] Group A: Excipients with good water wettability and compressibility when the tablet contains water-insoluble polymers, which exhibit tablet wetting times within 300 seconds, and tablet hardness exceeding that of excipients alone. 3 times that of the formulation.

[0085] Group B: Excipients with poor water wettability or compressible formability when the tablet contains a water insoluble polymer, which exhibit a tablet wetting time greater than 300 seconds, and a tab...

experiment example 2

[0094] To a mixture of D-mannitol (97 parts by weight) and various water-insoluble polymers (3 parts by weight) was added 80% (W / W) aqueous ethanol (5 parts by weight). The mixture was kneaded in a stainless steel container, then granulated with a No. 22 mesh sieve described in the Japanese Pharmacopoeia, and the resulting granules were dried in a ventilated box type drier at 50° C. for 2 hours to obtain granulated granules. The granulated granules (300 mg) were compression-molded (flat punch: 10 mm in diameter, tableting pressure: 1000 kg / punch) using a tableting analyzer (manufactured by Kikusui Seisakusho Co., Ltd.) to obtain tablets. The water wettability (wetting time) and hardness of each tablet were measured in accordance with the evaluation procedure in Experimental Example 1. Based on the measurement results (Table 2 below), the water-insoluble polymers are divided into the following 3 groups:

[0095] Group 1: Water-insoluble polymers that do not cause a decrease in...

experiment example 3

[0101] According to Examples 1 to 3 and Comparative Examples 1 to 2, tablets were prepared using various excipients in Experimental Example 1 and a water-insoluble polymer (HPMC-AS / HF). Tablet hardness was measured according to the evaluation procedure in Experimental Example 1. The disintegration time of the tablet in the oral cavity was measured by the following method.

[0102] Disintegration time of the tablet in the mouth:

[0103] Put one tablet in each mouth of three healthy adult males, and measure the time when the tablet is completely disintegrated with saliva when gently put in the mouth (ie, do not chew or vigorously move the tongue, etc.) to calculate the average value.

[0104] result)

[0105] The hardness of each tablet and the disintegration time of each tablet in the oral cavity are shown in Table 3 below. As can be seen from Table 3, the hardness of each tablet (i.e. the tablets of Examples 1 to 3) made by using the excipients of Group A is greater than 4...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
strengthaaaaaaaaaa
strengthaaaaaaaaaa
strengthaaaaaaaaaa
Login to view more

Abstract

Disclosed is an orally rapidly disintegrating tablet characterized in that the tablet can be produced in a conventional tablet production facility and has a satisfactory level of hardness for practical applications, and the change in properties of the tablet (i.e., decreased in hardness of the tablet, and delay of the time required for disintegration of the tablet in the oral cavity) are rarely caused by factors such as humidity. The orally rapidly disintegrating tablet has hardness of 40 N or more, can be disintegrated in the oral cavity within 60 seconds, and is produced by compression molding of a mixture of (a) an active ingredient, (b) an excipient having good water wettability, (c) a water-insoluble polymer that has good moldability and does not substantially cause the decrease in the water wettability of the excipient and (d) a disintegrating agent.

Description

technical field [0001] The present invention can be prepared by conventional tablet production equipment, and the present invention relates to a novel orally rapidly disintegrating tablet having practical formulation strength in various steps of preparation, dispensing, and formulation, and having rapid disintegration properties in the oral cavity, and the A preparation method of a novel orally rapidly disintegrating tablet. Background technique [0002] Generally, orally rapidly disintegrating tablets are highly required during medical procedures in patients suffering from Parkinson's disease, Alzheimer's disease, or dysphagia, and in patients who have difficulty getting up after surgery. At present, a variety of oral rapidly disintegrating tablets including preparations prepared by freeze-drying have been developed and marketed. The research and development of rapidly disintegrating tablets has become the mainstream at present. [0003] Orally rapidly disintegrating tabl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/138A61K31/4166A61K31/444A61K31/513A61K31/519A61K47/10A61K47/32A61K47/38
CPCA61K9/0056A61K9/2027A61K9/2054A61K31/138A61K31/4166A61K31/444A61K31/513A61K31/519A61P9/12A61P15/00A61P15/10A61P19/06A61P25/00A61P25/02A61P43/00A61K9/20A61K9/209A61K47/38
Inventor 杉本昌阳北冈健一齐藤泰纪上村胜治
Owner MITSUBISHI TANABE PHARMA CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap